Enfermedades emergentes y reemergentes en Yucatán a finales del ...

262
RA Góngora-Biachi, CJ Castro-Sansores, H Pérez-Carrillo y col.
of dominant Mycobacterial skin test reaction . J Infect Dis
1993;168:1553-1558.
PAPILLOMAVIRUS Y SU RELACION CON EL CAN-
CER CERVICOUTERINO.
1.- Shah KV. Papovaviridae En: Specter S, Lancs GJ, edit.
Clinical Virology Manual. New York: Elsevier. 1986:373-
386.
2.-Howley PM. Papillomavirinae: The viruses and their
replication. En: Field BN ed. Virology third ed. New York:
Raven Press. 1996 :2045-276.
3.- Meyers C, Franttini GM, HUdson JB, Laimins LA.
Biosynthesis of human papillomavirus from a continuous
cell line upon epithelial differentiation. Sciencie 1992;
257:971-973.
4.- Campion MJ. Manifestaciones clínicas y evolución de
la infección humana por papilomavirus . Clin N A Ginecol
Obstet.(Ed. en español) 1987; 2:263-288.
5.- Schneider A, Koustsky LA. Natural history and
epidemiologic features of genital HPV infection. En :Muñoz
N, Bosch FX, Shah KV. Meheus A ed. The epidemiology
of human papillomavirus and cervical cancer.Lyon: IARC
Scientific Publication No 119. 1992:25-52.
6.- Shah KV, Howley PM. Papillomaviruses. En : Fields
BN ed. Virology Third ed. New York: Raven Press.
1996:1077-2109.
7.- Lorincz AT, Reid R, Jenson B. Human papillomavirus
infection of the cervix : relative risk associations of 15
common anogenital types. Obstet Gynecol 1992; 79:328-
337.
8.- Vandenvelde C, Scheen R, Van Pachterbeke C, et al.
Prevalence of high risk gental papillomaviruses in belgian
female population determinated by fast multiple polymerase
chain reaction. J Med Virol 1992; 36:279-282.
9.- Schiffman MH, Bauer HM, Hoover RN, et al.
Epidemiologic evidencie showing that human
papillomavirus infection causes most cervical intraepithelial
neoplasia. J Natl Cancer Inst 1993; 85:958-964.
10.- Konya J, Veress G, Hernádi Z, Soós G, Czeglédy J,
Gergely L. Correlation of human papillomavirus 16 and 18
with prognostic factors in invasive cervical neoplasias. J
Med Virol 1995; 46:1-6.
11.- Williamsons AL, Brink NS, Dehaech CMV, Ovens S,
Oeters R, Rybicki EP : Typing of human papilomaviruses
in cervical carcinoma biopses from cape town. J Med Virol
1994 ;43 :231-237.
12.- Reeves WC, Caussy D, Brinton LA, et al. Case-control
study of human papilomaviruses and cervical cancer in
Latin America. Int J Cancer 1987; 40:450-454.
13.- Bosch FX, Muñoz N, deSanjosé S, et al. The causal
link between human papillomavirus and invasive cervical
cancer : a population-bsed case-control study in Colombia
and Spain. Int J Cancer 1992; 52:743-749-
14.- Muñoz N, Bosch FX. HPV and cervical neoplasia :
review of case-control and cohort studies. IARC Sci Publ
1992; 119:251-261.
15.- Toledo-Cuevas EM, García-Carrancá A. La proteína
p53 y los oncogenes de papilomavirus humanos en la
carcinogénesis del cuello uterino. Rev Invest Clin 1996;
48:59-68.
16.- Adams V, Moll C, Schmid M, Rodriguez C, Moss R,
Briner J. Detection and typing of human papillomavirus in
biopsy and cytological specimenes by polymerase chain
rection and restriction enzymes analysis. J Med Virol 1996;
48:161-170.
17.- González-Losa MR, Puerto-Solís M, Polanco-Marín
GG, et al. Identificación de papillomavirus 6/11,16/18 y
31/33/51 en cáncer cervicouterino en la ciudad de Mérida,
Yucatán, México. Estudio preliminar. Rev Biomed 1996;
7:79-84.
CARACTERÍSTICAS DE LAS EPIDEMIAS POR
VIRUS DEL DENGUE EN MÉRIDA, YUCATÁN,
MÉXICO.
1.- Westawey EG, Brinton MA, Gaidamovich SY.
Flaviviridae. Intervirology 1985; 24:183-92.
2.- Gubler DJ. Dengue. In: Epidemiology of arthropod-borne
viral disease, Monath TPM, editor. Boca Ratón (FL): CRC
Press 1988: 223-60.
3.- Loroño MA, Farfán JA, Rosado EP, Kuno G, Gubler
DJ. Epidemic dengue 4 in the Yucatan, Mexico; 1984. Rev
Inst Med Trop Sao Paulo 1993; 35: 449-55.
4.- Loroño MA, Farfán JA, Rosado EP, Arjona AI, Flores
LF, Manzano LA, Zavala JE. Prevalencia de anticuerpos
Revista Biomédica